Bicarbonate

Bicarbonate

SCHEMBL6989215

N=C(N)Cc1ccccc1.O=C(O)O

nearest known ligand 0.56

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

GSK3AGSK3BIMPA1

The experimentally established mechanism targets of Bicarbonate. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CES1 P23141 2/20 0.56
CES2 O00748 1/20 0.56
AKR1B1 P15121 1/20 0.56
HTR3E A5X5Y0 1/20 0.52
HTR3B O95264 1/20 0.52
HTR3A P46098 1/20 0.52
HTR3D Q70Z44 1/20 0.52
HTR3C Q8WXA8 1/20 0.52
PLAU P00749 1/20 0.50
HIF1A Q16665 1/20 0.50
IDO1 P14902 3/20 0.48
MEN1 O00255 1/20 0.48
KMT2A Q03164 1/20 0.48
HDAC8 Q9BY41 1/20 0.48
HDAC6 Q9UBN7 1/20 0.48
NOS3 P29474 1/20 0.48
NOS1 P29475 1/20 0.48
NOS2 P35228 1/20 0.48
FNTA P49354 1/20 0.47
FNTB P49356 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1238345 0.93 HTR3E (0.57) CES1CES2AKR1B1HTR3EHTR3B
Acetic Acid SCHEMBL3665413 0.91 CES1 (0.52) CES1CES2AKR1B1HTR3EHTR3B
Hydrochloric Acid SCHEMBL183500 0.91 IDO1 (0.56) CES1CES2AKR1B1HTR3EHTR3B
SCHEMBL27868161 0.85 HTR3E (0.47) CES1CES2AKR1B1HTR3EHTR3B
SCHEMBL13673467 0.84 PLA2G10 (0.53) CES1CES2AKR1B1HTR3EHTR3B
Phenylacetic Acid SCHEMBL27804643 0.82 AKR1B1 (0.77) CES1CES2AKR1B1PLAUHIF1A
SCHEMBL11344724 0.81 TSHR (0.57) CES1CES2AKR1B1HTR3EHTR3B
SCHEMBL5706141 0.80 CES1 (0.54) CES1CES2AKR1B1PLAUHIF1A
Phenylacetic Acid SCHEMBL28326941 0.80 AKR1B1 (0.74) CES1CES2AKR1B1PLAUHIF1A
SCHEMBL5756341 0.80 LMNA (0.57) HTR3EHTR3BHTR3AHTR3DHTR3C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0709386-B1 FUSED BENZAZEPINE DERIVATIVE AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME YAMANOUCHI PHARMA CO LTD (JP) 2003-05-07 EP disclosed
EP-1097920-A1 Intermediate for condensed benzazepine derivatives YAMANOUCHI PHARMACEUTICAL CO. LTD. (JP) 2001-05-09 EP disclosed
US-5856564-A CHEMICAL INTERMEDIATE FOR VASOPRESSIN ANTAGONIST YAMANOUCHI PHARMACEUTICAL CO., LTD. (JP) 1999-01-05 US disclosed
US-5723606-A Condensed benzazepine derivative and pharmaceutical composition thereof YAMANOUCHI PHARMACEUTICAL CO., LTD. (JP) 1998-03-03 US disclosed
EP-0709386-A1 FUSED BENZAZEPINE DERIVATIVE AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME YAMANOUCHI PHARMACEUTICAL CO. LTD. (JP) 1996-05-01 EP disclosed